Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.54 |
| ▸ | ACHE | P22303 | 1/20 | 0.51 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.50 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.50 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | BRAF | P15056 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29802310 | 1.00 | BRD4 (0.54) | BRD4ACHEMRGPRX4ABCB1ADRB2 | |
| SCHEMBL14120635 | 0.96 | ACHE (0.51) | BRD4ACHEMRGPRX4ABCB1ADRB2 | |
| SCHEMBL165220 | 0.89 | KDM4E (0.61) | ACHEABCB1BRAFALDH1A1KDM4E | |
| SCHEMBL29506042 | 0.89 | KDM4E (0.61) | ACHEABCB1BRAFALDH1A1KDM4E | |
| SCHEMBL21821534 | 0.82 | MRGPRX4 (0.54) | BRD4MRGPRX4ABCB1ADRB2ADRB1 | |
| SCHEMBL15283161 | 0.81 | TSHR (0.50) | BRD4ACHEMRGPRX4ABCB1ADRB2 | |
| SCHEMBL5270656 | 0.81 | MRGPRX4 (0.56) | BRD4MRGPRX4ABCB1ADRB2ADRB1 | |
| SCHEMBL6635718 | 0.81 | MEN1 (0.50) | BRD4ACHEBRAFALDH1A1KDM4E | |
| SCHEMBL14172820 | 0.81 | BRD4 (0.47) | BRD4ACHEMRGPRX4ABCB1ADRB2 | |
| SCHEMBL11805157 | 0.80 | MRGPRX4 (0.52) | BRD4ACHEMRGPRX4ABCB1ADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 563 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120118678-A | Color-adjustable organic room-temperature phosphorescent material and preparation method and application thereof | 江西科技师范大学 | 2025-06-10 | — | — | CN | claimed |
| CN-119930666-A | Doped red organic room-temperature phosphorescent material based on red phosphorescent emitter and preparation method thereof | 江西科技师范大学 | 2025-05-06 | — | — | CN | claimed |
| US-7074770-B1 | Method of DNA vaccination | SMITHKLINE BEECHAM CORPORATION (US) | 2006-07-11 | — | — | US | claimed |
| US-6461417-B1 | Ink compositions | XEROX CORPORATION | 2002-10-08 | — | — | US | claimed |
| EP-1107785-A1 | METHOD OF DNA VACCINATION | GLAXO GROUP LIMITED (GB) | 2001-06-20 | — | — | EP | claimed |
| US-6117223-A | Hot melt inks containing polyketones | XEROX CORPORATION (US) | 2000-09-12 | — | — | US | claimed |
| WO-2000012121-A1 | METHOD OF DNA VACCINATION | GLAXO GROUP LIMITED (GB) | 2000-03-09 | — | — | WO | claimed |
| US-5663029-A | DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| US-5618982-A | SIMPLE INDUSTRIAL PROCESS OF CATALYZING IN PRESENCE OF METALLIC PHOSPHATES | RHONE-POULENC CHIMIE (FR) | 1997-04-08 | — | — | US | claimed |
| JP-57056494-A | — | — | None | — | — | JP | disclosed |
| JP-59073539-A | — | — | None | — | — | JP | disclosed |
| US-20250333371-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2025-10-30 | — | — | US | disclosed |
| EP-3956334-B1 | COMPOUNDS FOR OPTICALLY ACTIVE DEVICES | AMO Ireland (IE) | 2025-09-24 | — | — | EP | disclosed |
| CN-120118678-A | Color-adjustable organic room-temperature phosphorescent material and preparation method and application thereof | 江西科技师范大学 | 2025-06-10 | — | — | CN | disclosed |
| US-4117230-A | ANTIDIABETIC AGENTS | PFIZER INC. (US) | 1978-09-26 | — | — | US | disclosed |
| US-4101677-A | Aminotetralins and use in inducing anesthesia | ABBOTT LABORATORIES (US) | 1978-07-18 | — | — | US | disclosed |
| US-4057582-A | Aminotetralins and use in inducing anesthesia | ABBOTT LABORATORIES (US) | 1977-11-08 | — | — | US | disclosed |
| US-3991207-A | TETRAHYDRONAPHTHYLAMINES AND L-3,4-DIHYDROXYPHENYL-ALANINE | PFIZER INC. (US) | 1976-11-09 | — | — | US | disclosed |
| US-3959480-A | Polycyclic gamma-pyrone-3-carboxaldehyde derivatives | WARNER-LAMBERT COMPANY (US) | 1976-05-25 | — | — | US | disclosed |
| US-3936488-A | Polycyclic dioxaborin complexes | WARNER-LAMBERT COMPANY (US) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250333371-A1 | COMPOUNDS | SDHA, PYGB, SLC18A2 | BRD4 3733/4885ACHE 31/4885MRGPRX4 2850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.